Trial Profile
A retrospective study evaluating treatment persistence with denosumab and oral bisphosphonates such as alendronate or risedronate in Swedish osteoporotic women older than 70 years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid; Risedronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 08 Jul 2017 New trial record